RE:RE:warrants
Toronto, Ontario TheNewswire March 3, 2021 - Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company"), (TSXV:VPT); (OTC:VPTDF) announces that it has applied to the TSX Venture Exchange (the TSXV) to extend the expiry date of 10,496,938 common share purchase warrants issued by the Corporation (the Warrants) in connection with a private placement financing on March 23, 2017 and previously extended to March 23, 2021. This Company will extend the expiry date by 60 days to May 23, 2021. The Warrants to be amended do not include any warrants issued to finders or agents. No other terms of the Warrants are to be amended and the exercise price remains at $0.50.